Ombrabulin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ombrabulin, covering 2015-10-30 to 2015-12-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel [Phase 2]